What is Condor?
Condor Software provides a sophisticated financial intelligence platform tailored for the life sciences and biopharmaceutical industry. It is recognized as an innovation-focused software provider that automates complex financial processes integral to clinical research. The platform enables organizations to enhance accuracy, efficiency, and real-time visibility in budgeting, forecasting, and vendor operations across their research and development workflows.
How much funding has Condor raised?
Condor has raised a total of $24M across 1 funding round:
Series A
$24M
Series A (2026): $24M with participation from 645 Ventures, Bramalea Partners, Insight Partners, Snr, and Felicis Ventures
Key Investors in Condor
645 Ventures
645 Ventures is a venture capital firm that invests in seed and Series A SaaS companies, focusing on partnering with innovative founders who aim to transform the future.
Bramalea Partners
Bramalea Partners specializes in partnering with exceptional expansion-stage technology companies, focusing on growth-oriented investments and leveraging their extensive experience to assist management teams in achieving sustainable and capital-efficient growth.
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies, providing capital and hands-on operational support to help businesses scale from early stage to IPO.
What's next for Condor?
The recent major strategic investment in Condor suggests the company is entering a significant scaling phase, likely moving beyond its initial development or seed stages. This infusion of capital is expected to fuel further platform development, market expansion, and potentially the acquisition of new talent to support its ambitious growth objectives. The focus on enterprise-level funding indicates a strategic push to capture a larger share of the life sciences financial technology market.
See full Condor company page
